158 related articles for article (PubMed ID: 34245502)
1. [Neurobiological effects of tenuigenin and the opportunity of it's using in the therapy of Alzheimer's and Parkinson's diseases (literature review).].
Berezutsky MA; Durnova NA; Sigareva LE
Adv Gerontol; 2021; 34(2):210-216. PubMed ID: 34245502
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective effects of tenuigenin in a SH-SY5Y cell model with 6-OHDA-induced injury.
Liang Z; Shi F; Wang Y; Lu L; Zhang Z; Wang X; Wang X
Neurosci Lett; 2011 Jun; 497(2):104-9. PubMed ID: 21536104
[TBL] [Abstract][Full Text] [Related]
3.
Deng X; Zhao S; Liu X; Han L; Wang R; Hao H; Jiao Y; Han S; Bai C
Pharm Biol; 2020 Dec; 58(1):410-416. PubMed ID: 32429787
[No Abstract] [Full Text] [Related]
4. Tenuigenin treatment decreases secretion of the Alzheimer's disease amyloid beta-protein in cultured cells.
Jia H; Jiang Y; Ruan Y; Zhang Y; Ma X; Zhang J; Beyreuther K; Tu P; Zhang D
Neurosci Lett; 2004 Aug; 367(1):123-8. PubMed ID: 15308312
[TBL] [Abstract][Full Text] [Related]
5. Tenuigenin protects dopaminergic neurons from inflammation via suppressing NLRP3 inflammasome activation in microglia.
Fan Z; Liang Z; Yang H; Pan Y; Zheng Y; Wang X
J Neuroinflammation; 2017 Dec; 14(1):256. PubMed ID: 29262843
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
[TBL] [Abstract][Full Text] [Related]
7. Tenuifolin, an extract derived from tenuigenin, inhibits amyloid-beta secretion in vitro.
Lv J; Jia H; Jiang Y; Ruan Y; Liu Z; Yue W; Beyreuther K; Tu P; Zhang D
Acta Physiol (Oxf); 2009 Aug; 196(4):419-25. PubMed ID: 19208093
[TBL] [Abstract][Full Text] [Related]
8. Combination of tenuigenin-based
Liang G; Gao C; Zhang L; Du H
Nat Prod Res; 2024 Mar; ():1-5. PubMed ID: 38529756
[TBL] [Abstract][Full Text] [Related]
9. [Alzheimer's disease: experimental and clinical researches of Chinese herbal medicine neurobiological effects (a review).].
Berezutsky MA; Durnova NA; Andronova TA; Sinichkina OV
Adv Gerontol; 2020; 33(2):273-281. PubMed ID: 32593241
[TBL] [Abstract][Full Text] [Related]
10. Tenuigenin promotes non-rapid eye movement sleep via the GABA
Zhang D; Zhang W; Deng S; Liu L; Wei H; Xue F; Yang H; Wang X; Fan Z
Biomed Pharmacother; 2023 Sep; 165():115259. PubMed ID: 37531785
[TBL] [Abstract][Full Text] [Related]
11. Tenuigenin attenuates α-synuclein-induced cytotoxicity by down-regulating polo-like kinase 3.
Zhou JX; Zhang HB; Huang Y; He Y; Zheng Y; Anderson JP; Gai WP; Liang ZG; Wang Y; Ren XM; Wang Q; Gong XL; Yang J; Wang X; Halliday G; Wang XM
CNS Neurosci Ther; 2013 Sep; 19(9):688-94. PubMed ID: 23710708
[TBL] [Abstract][Full Text] [Related]
12. Novel Therapeutics for the Treatment of Alzheimer's and Parkinson's Disease.
Singh K; Yadav D; Chauhan PS; Mishra M; Jin JO
Curr Pharm Des; 2020; 26(7):755-763. PubMed ID: 31914906
[TBL] [Abstract][Full Text] [Related]
13. New therapeutic strategy for Parkinson's and Alzheimer's disease.
Esposito E; Cuzzocrea S
Curr Med Chem; 2010; 17(25):2764-74. PubMed ID: 20586718
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial dysfunction and oxidative damage in Alzheimer's and Parkinson's diseases and coenzyme Q10 as a potential treatment.
Beal MF
J Bioenerg Biomembr; 2004 Aug; 36(4):381-6. PubMed ID: 15377876
[TBL] [Abstract][Full Text] [Related]
15. Tenuigenin promotes proliferation and differentiation of hippocampal neural stem cells.
Chen Y; Huang X; Chen W; Wang N; Li L
Neurochem Res; 2012 Apr; 37(4):771-7. PubMed ID: 22179853
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective Effects of Citrus Fruit-Derived Flavonoids, Nobiletin and Tangeretin in Alzheimer's and Parkinson's Disease.
Braidy N; Behzad S; Habtemariam S; Ahmed T; Daglia M; Nabavi SM; Sobarzo-Sanchez E; Nabavi SF
CNS Neurol Disord Drug Targets; 2017; 16(4):387-397. PubMed ID: 28474543
[TBL] [Abstract][Full Text] [Related]
17. Incretin and insulin signaling as novel therapeutic targets for Alzheimer's and Parkinson's disease.
Nowell J; Blunt E; Edison P
Mol Psychiatry; 2023 Jan; 28(1):217-229. PubMed ID: 36258018
[TBL] [Abstract][Full Text] [Related]
18. Glycation in Parkinson's disease and Alzheimer's disease.
Vicente Miranda H; El-Agnaf OM; Outeiro TF
Mov Disord; 2016 Jun; 31(6):782-90. PubMed ID: 26946341
[TBL] [Abstract][Full Text] [Related]
19. Role of mtDNA disturbances in the pathogenesis of Alzheimer's and Parkinson's disease.
Antonyová V; Kejík Z; Brogyányi T; Kaplánek R; Pajková M; Talianová V; Hromádka R; Masařík M; Sýkora D; Mikšátková L; Martásek P; Jakubek M
DNA Repair (Amst); 2020; 91-92():102871. PubMed ID: 32502755
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic Potential of Baicalein in Alzheimer's Disease and Parkinson's Disease.
Li Y; Zhao J; Hölscher C
CNS Drugs; 2017 Aug; 31(8):639-652. PubMed ID: 28634902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
